Concerning harm-benefit ratio in a recent trial about escitalopram for generalized anxiety disorder

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	295-296
Number of pages	2
Journal	Journal of Child and Adolescent Psychopharmacology
Volume	33
Publication status	Published - 2023

Cite this

@article{566d57f9d18640e4a0baa95da8f84425,

title = "Concerning harm-benefit ratio in a recent trial about escitalopram for generalized anxiety disorder",

author = "M Pl{\"o}derl and MA Horowitz and MP Hengartner",

year = "2023",

language = "undefiniert/unbekannt",

volume = "33",

pages = "295--296",

journal = "Journal of Child and Adolescent Psychopharmacology",

}